ArticleJTCVS open2026
Ross procedure after prior aortic valve intervention: Outcomes from the North American Ross Consortium database.
Article in JTCVS open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Excellent results for the Ross procedure have been demonstrated in selected, single-center series. Outcomes for higher-risk patients, including those with prior aortic valve intervention, are not well described, however. Methods: This multicenter, retrospective analysis of adult recipients of the Ross procedure between 1994 and 2025 at 4 high-volume aortic centers compared patients with prior surgical aortic valve intervention (SAVI) and those with no prior aortic valve intervention. The primary outcome was operative mortality. Secondary outcomes included perioperative outcomes, longitudinal mortality, and reintervention. Results: The study cohort comprised 594 patients, including 29 with prior SAVI and 565 without prior SAVI. The median age at surgery was 38 years (interquartile range [IQR], 32-48 years) for the SAVI group and 42 years (IQR, 32-51 years) for the non-SAVI group ( Conclusions: Cardiac causes of death were absent in those with prior SAVI following the Ross procedure, suggesting that the Ross procedure can be safe in these patients when performed by skilled, experienced surgeons. Further studies are needed to more fully assess Ross procedure outcomes in patients with prior SAVI.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.